Ballentine Partners’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Buy
6,703
+1,575
+31% +$445K 0.02% 240
2026
Q1
$1.37M Sell
5,128
-1,425
-22% -$394K 0.02% 282
2025
Q4
$1.8M Sell
6,553
-2,975
-31% -$834K 0.03% 208
2025
Q3
$2.75M Buy
9,528
+99
+1% +$29.3K 0.04% 154
2025
Q2
$3.12M Buy
9,429
+1,463
+18% +$472K 0.05% 136
2025
Q1
$2.62M Buy
7,966
+1,383
+21% +$417K 0.05% 148
2024
Q4
$1.82M Sell
6,583
-1,143
-15% -$364K 0.03% 190
2024
Q3
$2.68M Buy
7,726
+691
+10% +$238K 0.05% 139
2024
Q2
$2.33M Sell
7,035
-985
-12% -$340K 0.04% 140
2024
Q1
$2.91M Buy
8,020
+1,070
+15% +$352K 0.06% 115
2023
Q4
$2.08M Buy
6,950
+1,740
+33% +$508K 0.04% 139
2023
Q3
$1.49M Buy
5,210
+333
+7% +$95K 0.04% 152
2023
Q2
$1.37M Buy
4,877
+1,231
+34% +$321K 0.03% 161
2023
Q1
$932K Sell
3,646
-341
-9% -$99.4K 0.02% 206
2022
Q4
$1.32M Buy
3,987
+515
+15% +$163K 0.04% 144
2022
Q3
$963K Buy
3,472
+801
+30% +$225K 0.03% 161
2022
Q2
$704K Buy
2,671
+82
+3% +$21.1K 0.02% 191
2022
Q1
$621K Buy
2,589
+23
+0.9% +$5.38K 0.02% 231
2021
Q4
$589K Buy
2,566
+238
+10% +$50.6K 0.02% 240
2021
Q3
$466K Buy
2,328
+420
+22% +$91.3K 0.02% 251
2021
Q2
$452K Buy
1,908
+39
+2% +$9.74K 0.02% 250
2021
Q1
$451K Buy
1,869
+401
+27% +$89.4K 0.02% 236
2020
Q4
$306K Sell
1,468
-636
-30% -$125K 0.01% 283
2020
Q3
$356K Buy
2,104
+7
+0.3% +$1.23K 0.02% 258
2020
Q2
$394K Buy
2,097
+55
+3% +$10.4K 0.02% 231
2020
Q1
$362K Buy
2,042
+162
+9% +$31.4K 0.02% 224
2019
Q4
$384K Buy
1,880
+189
+11% +$34.7K 0.02% 257
2019
Q3
$257K Buy
1,691
+6
+0.4% +$976 0.01% 313
2019
Q2
$266K Sell
1,685
-24
-1% -$3.76K 0.01% 314
2019
Q1
$275K Sell
1,709
-618
-27% -$113K 0.01% 257
2018
Q4
$443K Buy
2,327
+1,181
+103% +$246K 0.03% 196
2018
Q3
$239K Buy
+1,146
New +$212K 0.01% 301
2018
Q1
Sell
-1,182
Closed -$239K 367
2017
Q4
$239K Sell
1,182
-2
-0.2% -$398 0.01% 308
2017
Q3
$221K Buy
+1,184
New +$211K 0.01% 331

Other funds holding CI

Ballentine Partners's CI Position: Q2 2026 in Review

Ballentine Partners increased its Cigna (CI) stake by 31% in Q2 2026, buying an estimated $445K and bringing the position to 6,703 shares worth $1.85M. The position accounts for 0.02% of the portfolio, ranked #240.

Ballentine Partners first reported a position in CI in Q3 2017 and has held it in 34 quarters since. The position peaked at $3.12M in Q2 2025. 256 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Ballentine Partners held 6,703 shares of Cigna worth $1.85M as of Q2 2026.
  • Ballentine Partners bought 1,575 Cigna shares in Q2 2026, an estimated $445K.
  • Cigna made up 0.02% of Ballentine Partners's portfolio in Q2 2026, its #240 holding.
  • Ballentine Partners first reported a position in Cigna in Q3 2017 and has held it in 34 quarters since.
  • Ballentine Partners's Cigna position peaked at $3.12M in Q2 2025.
  • 256 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.